基本信息
浏览量:20
职业迁徙
个人简介
Dr. Cappellini is being recognized for her research in novel therapeutic challenges for thalassemias and sickle cell disease, including gene therapy and other pharmacologic treatments. These new treatments could significantly change the survival and quality of life of people suffering from these diseases. She has been involved in translational and clinical research focused on thalassemia for nearly 4 decades. Through the advent of techniques of molecular biology in the 1980s, Dr. Cappellini characterized the genotypes and phenotypes of beta-thalassemia major, beta-thalassemia intermedia, alpha-thalassemia, and rare combinations of thalassemias that informed researchers’ understanding of the natural history of these disorders and allowed for molecular-based genetic counseling and prenatal diagnosis.
研究兴趣
论文共 727 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Annals of Hematologyno. 3 (2024): 1025-1026
ANNALS OF HEMATOLOGYno. 3 (2024): 957-967
British Journal of Haematologyno. 5 (2023): 824-831
Blood Cells Molecules and Diseases (2023): 102705-102705
引用1浏览0引用
1
0
Science Translational Medicineno. 698 (2023)
Drug Design Development and Therapy (2023): 1583-1591
引用0浏览0引用
0
0
HemaSphereno. S3 (2023): e8473180-e8473180
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn